Mobile Cardiac Telemetry Systems Market - By Product Type, By Indication, By End Use - Global Forecast, 2026 - 2035

Mobile Cardiac Telemetry Systems Market Size

The global mobile cardiac telemetry systems market was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.4 billion in 2026 to USD 4 billion by 2035, expanding at a CAGR of 12.6%, according to the latest report published by Global Market Insights Inc. This steady growth is driven by the increasing incidence of cardiac disorders, favorable government policies, growing aging population, and technological advancements in cardiac telemetry systems.
 

Mobile cardiac telemetry is a form of ambulatory cardiac monitoring that allows patients to perform daily routine work while their heart activity is tracked throughout the day. Unlike traditional Holter ECG, MCT systems automatically detect and transmit abnormal heart rhythms to a monitoring center without requiring patient intervention. A patch or lead-based portable sensors that records ECG signals continuously, when an abnormal rhythm like arrhythmia, bradycardia is detected, the device automatically transmits data via mobile networks to a remote monitoring center.
 

Major companies in the industry include Medtronic plc, iRhythm Technologies, Boston Scientific Cardiac Diagnostics, Zoll Medical Corporation, and Koninklijke Philips N.V. In addition to this, investments are growing in healthcare, and governments are also supporting by reinforcing policies like reimbursement policies, financial incentives, regulatory support and fast-track approvals. These factors are positively influencing the market expansion across both developed and emerging regions.
 

The market increased from USD 1 billion in 2022 to USD 1.2 billion in 2024. This growth can be primarily linked to the increasing incidence of cardiac disorders and the rising awareness among people for cardiac health. With the growing aging population, the demand for continuous and proactive cardiac monitoring is escalating rapidly. Furthermore, healthcare system is shifting towards patient-centric diagnostics, which has made mobile cardiac telemetry systems the preferred choice, for early detection of cardiac issues and reducing dependency on hospital-based monitoring.
 

The surge in cardiac disorder incidence is one of the key factors aiding in the growth of the mobile cardiac telemetry systems industry, as early detection is critical for improving outcomes. For instance, according to World Heart Federation, in 2021, over 500 million people worldwide are affected by CVDs, with ischemic heart disease and stroke making up 85% of these deaths. This burden is disproportionately high in low- and middle-income countries, where 4 out of 5 CVD deaths occur.
 

This escalating global burden of cardiovascular diseases highlights the critical importance of timely diagnosis and intervention. Mobile cardiac telemetry systems address this need by offering continuous, remote monitoring capabilities that enable early detection of arrhythmias and other cardiac irregularities. Their integration into clinical workflows not only improves patient outcomes but also reduces hospital readmissions and healthcare costs, thereby further fueling market growth.
 

Additionally, there has been an increase in the geriatric population base worldwide. This factor is supporting the significant growth of the mobile cardiac telemetry systems market. According to the World Health Organization (WHO), the number of people above 60 years of age globally is projected to reach 1.4 billion by 2030 from 1.1 billion in 2023. These statistics show that regular monitoring is essential, as elderly individuals are more susceptible to arrhythmias and other cardiovascular conditions, making real-time, remote monitoring essential to reduce hospitalizations and improve outcomes.
 

Mobile cardiac telemetry (MCT) systems are an integral part of cardiac monitoring solutions. These innovative, wearable monitoring technologies like wearable atrial fibrillation detection devices facilitate real-time remote monitoring of a patient’s cardiac rhythm and supply health care providers with an opportunity to identify and respond to arrhythmias and other cardiac anomalies in a timely manner.
 

Mobile Cardiac Telemetry Systems Market Trends

• The market has seen rapid evolution due to technological advancements in cardiac telemetry systems. Wearable patch sensors provide ultra-thin and flexible patches that integrate ECG and motion sensors, enabling real-time detection of cardiac rhythms without disruption on patient’s daily activities.
   
• Their lightweight and adhesive design ensures high patient compliance, particularly in outpatient and home-care settings. Wireless connectivity enables seamless data transmission via bluetooth or cellular networks to cloud-based platforms. For instance, Medtronic’s LINQ II implantable cardiac monitor exemplifies these capabilities by offering continuous monitoring with secure wireless data transfer and integration into remote patient management systems.
   
• Additionally, cloud-based platforms in MCT systems provide integration with EHRs. Cardiologists, technicians, and patients can have access to this integrated data regardless of location, facilitating opportunities for virtual consultations and second opinions.
   
• Moreover, leading companies in the mobile cardiac telemetry (MCT) systems market are increasingly focusing on advanced device designs and automated data management workflows. As global healthcare systems emphasize early detection and digital transformation, MCT platforms are evolving into comprehensive real-time cardiac monitoring solutions that support personalized care, enable remote diagnostics, and minimize reliance on hospital-based services, thereby further supporting the growth of the market.
   

Mobile Cardiac Telemetry Systems Market Analysis

Based on the product type, the market is segmented into lead- based and patch-based. The lead-based segment led this market in 2025, accounting for the highest market share because of its ability to provide multi-lead ECG recording and high diagnostic accuracy. This segment was valued at USD 821.6 million in 2025 and is projected to reach USD 2.6 billion by 2035, growing at a CAGR of 12.8%.
 

• Lead-based systems employ multi-lead ECG configurations with adhesive electrodes and external leads, delivering high accuracy in detecting arrhythmias and monitoring ischemic events. These systems are well-established in clinical practice and form an integral part of standard hospital workflows, making them a preferred choice in both hospital settings and specialty clinics.
   
• These systems typically employ multiple leads attached to the patient's chest to capture cardiac activity from different angles and perspectives. This multi-lead configuration allows for comprehensive monitoring of the heart's electrical activity, enhancing diagnostic precision and the detection of subtle abnormalities.
   
• For example, Boston Scientific’s BodyGuardian MINI PLUS provides multi-mode monitoring. This configuration enables multi-lead ECG recording for improved signal accuracy and clearer arrhythmia detection. It is particularly useful for patients requiring high-fidelity monitoring over extended periods.
   
• On the other hand, patch-based MCT systems are considered as a moderately growing segment due to the need for both ambulatory care and home-based cardiac monitoring. These systems generally use wireless, adhesive patches with embedded sensors that transmit ECG data over cellular service or bluetooth networks. Together, these technologies are driving improved diagnostic precision, enhanced patient compliance, and broader accessibility, thereby reinforcing the overall growth trajectory of the market.
   

Based on the indication, the mobile cardiac telemetry systems market is segmented into angina pectoris, coronary artery disease, atherosclerosis, heart failure, stroke, other indications. The angina pectoris segment accounted for the highest market share of 28.6% in 2025.
 

• Angina pectoris is characterized by chest discomfort due to reduced blood flow to the heart muscle, often presents intermittently and unpredictably. It is a primary symptom of coronary heart disease and requires timely detection to prevent severe cardiac events.
   
• Mobile cardiac telemetry (MCT) systems play a vital role in managing this condition by capturing ST-segment changes and ischemic patterns during daily activities. These systems allow patient-activated recordings during symptomatic episodes and provide clinicians with actionable insights for risk stratification and medication adjustments based on rhythm trends.
   
• The growing prevalence of coronary heart disease underscores the importance of advanced monitoring solutions. According to the Centers for Disease Control and Prevention (CDC), in 2022, coronary heart disease was diagnosed in approximately 371,506 individuals in the U.S., highlighting its significant health burden. Furthermore, CDC data indicates that the self-reported prevalence of angina among U.S. adults is around 1.5% to 1.7%, with higher rates observed in older populations. Similarly, NHS data shows that in 2024 nearly 2 million people in the UK are living with angina, reflecting its widespread impact across developed regions.
   
• Technological advancements in MCT systems, such as AI-driven analytics and cloud-based platforms, enhance diagnostic accuracy and patient compliance. These innovations enable early detection of ischemic changes, reduce hospital readmissions, and support personalized treatment strategies.
   
• As healthcare providers increasingly adopt MCT systems for angina management, this segment is expected to witness robust growth.
   

Based on end use, the mobile cardiac telemetry systems market is segmented into hospitals, specialty clinics, diagnostic centers, homecare settings, other end users. The hospitals segment accounted for the highest market share of 47.5% in 2025.
 

• The hospital segment contributes to the largest market share in the market. Its growth is being propelled by current cardiac monitoring infrastructure availability and the presence of trained cardiologists. Hospitals continue to be dominating institutions in diagnosing and managing heart disease and post-operative heart care.
   
• Growth in this segment is further supported by high patient volumes and centralized telemetry systems that streamline cardiac monitoring workflows. Hospitals often integrate MCT solutions within cardiology information systems and electronic health records (EHRs), enabling automated data submission and centralized reporting. This interoperability enhances clinical efficiency, reduces manual errors, and supports timely decision-making for complex cardiac cases.
   
• Therefore, the increasing adoption of cloud-based platforms and remote connectivity within hospital networks will further strengthen their role in delivering real-time cardiac insights, thereby propelling market growth.
   

North America Mobile Cardiac Telemetry Systems Market
 

North America dominated the global market with the highest market share of 40.4% in 2025. The region has advanced healthcare infrastructure and the higher rate of adoption of innovative medical technologies. Further, there is an increasing prevalence of cardiac disorders in the U.S. and Canada, thus propelling the growth of this market.
 

• The North America healthcare ecosystem supports MCT adoption with established reimbursement policies, public awareness, and R&D support.
   
• The U.S. mobile cardiac telemetry systems market was valued at USD 157.0 million and USD 170.2 million in 2022 and 2023, respectively. The market size reached USD 206.7 million in 2025, growing from USD 182.1 million in 2024
   
• The aging U.S. population and the growing burden of cardiovascular disease, particularly coronary artery disease and atrial fibrillation, will drive continued demand for long-term, real-time ECG monitoring. According to the Centers for Disease Control and Prevention, 12.1 million U.S. population is projected to have atrial fibrillation by 2030, underscoring the need for scalable cardiac telemetry solutions.
   
• Moreover, the market is further helped by fewer regulatory hurdles and a robust healthcare system facilitating quicker integration of wearable telemetry into standard care.
   
• The major companies such as Boston Scientific and iRhythm Technologies are actively expanding their product portfolios to meet evolving needs in this market.
   
• With growing emphasis on cloud-based diagnostics, remote collaboration, and EHR integration, the North America market is expected to maintain steady revenue growth supported by both public health initiatives and private sector innovation.
   

Europe Mobile Cardiac Telemetry Systems Market
 

Europe market accounted for USD 276.9 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Europe’s market is driven by growing technological advancements in wearable sensors and rising prevalence of cardiac disorders. According to the European Commission, in 2021, heart and circulatory diseases caused 1.71 million deaths in the European Union, making 32.4% of all deaths. This number suggests growing prevalence of cardiac disorders across Europe.
   
• Germany, France, and the UK are leading adopters of advanced MCT platforms, leveraging wearable telemetry devices and AI-powered analytics to enhance arrhythmia detection and patient management. These countries are incorporating patch-based and lead-based telemetry systems into national health programs, supporting early diagnosis and reducing hospital readmissions. Favorable reimbursement frameworks, digital health initiatives, and public-private collaborations are accelerating market growth.
   

Germany mobile cardiac telemetry systems market is projected to experience steady growth between 2026 and 2035.
 

• The market in Germany is expanding steadily, driven by rising cardiovascular disease incidence and strong healthcare infrastructure. For instance, according to World Heart Federation, around 4 million people are living with heart failure in Germany, along with that Germany recorded approximately 500,000 hospitalizations due to heart failure in 2019.
   
• Such statistics show that there is a requirement for accelerating demand for remote cardiac monitoring. Further, hospitals and speciality clinics are increasingly adopting wearable cardiac monitoring sensors to enhance diagnostic accuracy and patient safety in Germany.
   

Asia Pacific Mobile Cardiac Telemetry Systems Market
 

The Asia Pacific region is projected to be valued at USD 315.5 million in 2025 and is expected to reach USD 1.1 billion by 2035.
 

• The region is expected to grow at the fastest CAGR because of the surge in awareness about cardiovascular diseases, government funding to healthcare infrastructure, and increasing disposable incomes.
   
• Furthermore, the region’s growing elderly population is more susceptible to develop cardiac disorders. In Asia Pacific, according to Institute for Health Metrics and Evaluation, age-standardized CVD prevalence ranged from 5,881.0 per 100,000 in South Asia to 11,342.6 per 100,000 in Central Asia. As awareness and adoption of remote cardiac monitoring technologies accelerate, Asia Pacific is expected to drive substantial market growth over the forecast period.
   

Japan mobile cardiac telemetry systems market is poised to witness lucrative growth between 2026 - 2035.
 

• The country’s aging demographic is a major driver, with 29.1% of the population aged 65 and older as of 2023, according to Statista. This trend is increasing demand for early detection and preventive care, boosting adoption of digital and AI-powered MCT systems.
   
• Japan’s government is actively promoting digital health adoption through public awareness campaigns, reimbursement support, and integration of remote monitoring into chronic disease management. These initiatives are expanding access to cardiac diagnostics and positioning Japan as a regional leader in mobile cardiac telemetry market.
   

Latin America Mobile Cardiac Telemetry Systems Market
 

Brazil is experiencing significant growth in the market, driven by its expanding adoption of chronic disease management.
 

• In Brazil, cardiovascular diseases were among the most common chronic diseases. According to the World Heart Observatory, in 2021, Brazil recorded an age-standardized cardiovascular disease (CVD) incidence rate of 547 per 100,000 population. This number reflects newly diagnosed cases and rising prevalence of CVDs in Brazil. This growing burden is accelerating demand for non-invasive, remote cardiac monitoring.
   
• Additionally, Brazil’s aging population is contributing to increased demand for telemetry systems. As per the Brazilian Institute of Geography and Statistics, the number of individuals aged 65 and older reached 22.17 million in 2022, accounting for 10.9% of the total population, a 57.4% increase since 2010. This demographic shift is more prone to suffer from cardiovascular disorders, driving adoption of mobile cardiac telemetry systems.
   

Middle East and Africa Mobile Cardiac Telemetry Systems Market
 

The market in Saudi Arabia is expected to experience significant and promising growth from 2026 to 2035.
 

• Saudi Arabia's elderly population is rising at a much faster pace than any other segment. It is estimated that the population aged 60 years and above will grow from 2 million (5.9 percent of the total population) in 2020 to 10.5 million by 2050.
   
• This population shift will lead to the rising demand for real-time, wearable ECG monitoring. Mobile cardiac telemetry systems are being used to reduce hospital readmissions, support post-operative care, and enable prompt management of conditions like atrial fibrillation and ischemic heart disease, thereby supporting growth of market.
   

Mobile Cardiac Telemetry Systems Market Share

• The top 5 players, such as Medtronic plc, iRhythm Technologies, Boston Scientific Cardiac Diagnostics, Zoll Medical Corporation, and Koninklijke Philips N.V. collectively held 65% of the total market share. These companies will retain their leadership through a combination of technology, integrated artificial intelligence (AI), and partnerships with hospitals, cardiac centers, and telemonitoring providers.
   
• For example, iRhythm Technologies has been the leading company in this sector with their Zio AT patch, providing ECG monitoring for as long as 14 days without interruption. iRhythm excels by leveraging deep-learning algorithms, ensuring high patient compliance, and integrating seamlessly with provider platforms such as hospitals and telemonitoring systems. These capabilities position iRhythm MCT systems as a preferred solution for managing complex outpatient cases and elderly care scenarios.
   
• Meanwhile, new players are starting to take hold in this sector, such as Biotricity, ScottCare Cardiovascular Solutions, Telerhythmics LLC. These companies are trying to create new territory for themselves with low-cost, AI-based telemetry platforms, or cloud-based telemetry platforms. All of these companies are addressing unmet demands in the industry around telecardiology, home monitoring, and interoperability of data ecosystems.
   
• Therefore, the mobile cardiac telemetry market is expected to remain highly competitive, with leading players leveraging advanced technologies, AI integration, and strategic partnerships to sustain dominance.
   

Mobile Cardiac Telemetry Systems Market Companies

Few of the prominent players operating in the mobile cardiac telemetry systems industry include:
 

• ACS Diagnostics
• AliveCor
• Baxter International Inc.
• BIOTRICITY INC.
• Biotronik
• Bittium
• Boston Scientific Cardiac Diagnostics Inc.
• Cardiosense
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Medicomp Systems
• Medtronic plc
• ScottCare Cardiovascular Solutions
• Telerhythmics LLC
• Zoll Medical Corporation
  
   
• Boston Scientific Cardiac Diagnostics Inc.

Boston Scientific’s BodyGuardian MINI PLUS is a compact, waterproof telemetry device offering near-real-time cardiac monitoring for up to 30 days. Integrated with the PatientCare platform, it enables timely detection of arrhythmias and supports clinical decision-making. The BodyGuardian MINI PLUS is part of Boston Scientific’s larger portfolio of rhythm management solutions with minimally invasive wearable monitors, insertable cardiac devices and remote monitoring services to provide cardiac care throughout the globe.
 

•  iRhythm Technologies

iRhythm is leading with its flagship Zio AT heart monitor device, a patch-based monitoring device, used to track continuous ECG monitoring for up to 14 days. Backed by its ZEUS deep-learning artificial intelligence technology device, the system produces clinically actionable reports of up to 99% agreement. The redesigned MyZio patient experience app allows patients to log symptoms and gain additional health literacy through educational content. With full FDA clearance and CE marking, iRhythm’s solution is trusted for its accuracy, patient compliance, and ability to support end-to-end cardiac monitoring.
 

• Koninklijke Philips N.V.

Koninklijke Philips N.V. stands out with its Cardiac Ambulatory Monitoring platform, which extends heart care beyond hospital walls. The platform is equipped with several wear options such as patch, lead wire, and FLEX configurations to meet the individual preferences of the patient and clinical needs. With consolidated EMR use, the turnaround time for reports is rapid (24-48 hours) and the mobile apps are easy to use. This makes Philips the preferred cardiac diagnostic company to build a scalable diagnosis. Philips' real strength is that it combines AI-powered insights into heart health together with automation of workflow allowing clinicians to make faster and better-informed decisions.
 

Mobile Cardiac Telemetry Systems Industry News:

• In March 2022, ZOLL introduced the Arrhythmia Management System (AMS), a next-gen MCT solution that combines biometric data (heart rate, respiratory rate, posture) with traditional ECG telemetry. Validated by the MAPS Trial, the system demonstrated improved treatment planning in over 60% of patients, marking a significant leap in personalized cardiac care.
   
• In July 2025, Lucem Health and iRhythm Technologies announced a strategic partnership to revolutionize cardiac care through predictive monitoring. By integrating Lucem’s Reveal AI platform with iRhythm’s diagnostic Zio service, the collaboration sought to detect arrhythmias before symptoms appear, offering proactive and preventive care to over 27 million U.S. population at elevated risk for cardiac events. This innovative approach represents a major shift from traditional reactive models to a data-driven, anticipatory healthcare paradigm.
   

The mobile cardiac telemetry systems market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 - 2035 for the following segments:

Market, By Product Type

• Lead-based
• Patch-based

Market, By Indication

• Angina pectoris
• Coronary artery disease
• Atherosclerosis
• Heart failure
• Stroke
• Other indications

Market, By End Use

• Hospitals
• Specialty clinics
• Diagnostic centres
• Homecare settings
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE